ERBB2 and cancer: Interestingly, similar observations were shown by Hu and Steinmetz in 2021 using a PhMV-based cancer vaccine, where anti-PhMV titers were higher than those against the chemically coupled HER (human epidermal growth factor receptor)-2-derived CH401 epitope (Hu and Steinmetz, 2021).